volume 11, issue Suppl 1, PP208 2008
DOI: 10.1186/1758-2652-11-s1-p208
View full text
|
|
Share

Abstract: Interference of clinical laboratory assays by endogenous and exogenous substances in the blood is well known. To date, there are no clear guidelines on the testing of hemolyzed plasma in clinical laboratories. A conservative approach of alerting the physician with re-sampling is advised. This study focuses on the effect of processed (2006/2007), hemolyzed (in vivo/in vitro) plasma (visual inspection) on genotyping (virco ® TYPE HIV 1) and phenotyping (Antivirogram ®) success at Virco.

Search citation statements

Order By: Relevance

Paper Sections

0
0
0
0
0

Citation Types

0
0
0

Publication Types

Select...

Relationship

0
0

Authors

Journals